Return to homepagePandemic Pact

Chimeric insect-specific viruses as novel vaccines for mosquito-borne diseases

  • Funded by National Health and Medical Research Council (NHMRC)
  • Total publications:0 publications

Grant number: GA60396

Grant search

Key facts

  • Disease

    Zika virus disease, Dengue

  • Start & end year

    2020
    2022

  • Known Financial Commitments (USD)

    $709,288.74

  • Funder

    National Health and Medical Research Council (NHMRC)

  • Principal Investigator

    N/A

  • Research Location

    Australia

  • Lead Research Institution

    University of Queensland

  • Research Priority Alignment

    N/A

  • Research Category

    Vaccines research, development and implementation

  • Research Subcategory

    Pre-clinical studies

  • Special Interest Tags

    N/A

  • Study Type

    Non-Clinical

  • Clinical Trial Details

    N/A

  • Broad Policy Alignment

    Pending

  • Age Group

    Not Applicable

  • Vulnerable Population

    Not applicable

  • Occupations of Interest

    Not applicable

Abstract

Outbreaks of mosquito-borne diseases such as Zika, dengue and yellow fever continue in developing countries around the world. The emergence of new mosquito-borne pathogens is also a proven threat. In this proposal we will develop a new patented system for generating safe vaccines against mosquito-transmitted viral diseases to facilitate their commercialization. This includes optimization of scale up production for vaccine manufacture and final protection studies in animals.